Modeling the evolution of ETV6-RUNX1–induced B-cell precursor acute lymphoblastic leukemia in mice

  • Louise van der Weyden
    Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
  • George Giotopoulos
    Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom;
  • Alistair G. Rust
    Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
  • Louise S. Matheson
    The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom;
  • Frederik W. van Delft
    The Institute of Cancer Research, Section of Haemato-Oncology, Surrey, United Kingdom; and
  • Jun Kong
    Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
  • Anne E. Corcoran
    The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom;
  • Mel F. Greaves
    The Institute of Cancer Research, Section of Haemato-Oncology, Surrey, United Kingdom; and
  • Charles G. Mullighan
    St Jude Children's Research Hospital, Memphis, TN
  • Brian J. Huntly
    Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom;
  • David J. Adams
    Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;

説明

<jats:title>Abstract</jats:title><jats:p>The t(12;21) translocation that generates the ETV6-RUNX1 (TEL-AML1) fusion gene, is the most common chromosomal rearrangement in childhood cancer and is exclusively associated with B-cell precursor acute lymphoblastic leukemia (BCP-ALL). The translocation arises in utero and is necessary but insufficient for the development of leukemia. Single-nucleotide polymorphism array analysis of ETV6-RUNX1 patient samples has identified multiple additional genetic alterations; however, the role of these lesions in leukemogenesis remains undetermined. Moreover, murine models of ETV6-RUNX1 ALL that faithfully recapitulate the human disease are lacking. To identify novel genes that cooperate with ETV6-RUNX1 in leukemogenesis, we generated a mouse model that uses the endogenous Etv6 locus to coexpress the Etv6-RUNX1 fusion and Sleeping Beauty transposase. An insertional mutagenesis screen was performed by intercrossing these mice with those carrying a Sleeping Beauty transposon array. In contrast to previous models, a substantial proportion (20%) of the offspring developed BCP-ALL. Isolation of the transposon insertion sites identified genes known to be associated with BCP-ALL, including Ebf1 and Epor, in addition to other novel candidates. This is the first mouse model of ETV6-RUNX1 to develop BCP-ALL and provides important insight into the cooperating genetic alterations in ETV6-RUNX1 leukemia.</jats:p>

収録刊行物

  • Blood

    Blood 118 (4), 1041-1051, 2011-07-28

    American Society of Hematology

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ